Sign Up
Stories
Revolutionizing Arrhythmia Care with $16 Million Funding
Share
FDA Breakthrough Device Designation for ...
Innovative Cardiac Support Devices Recei...
Positive Results for Supira Medical and ...
AI-Powered Raspberry Pi Stethoscope Inno...
Afya Limited Expands Medical Seats in Br...
Attune Medical's Growth in Esophageal Te...
Overview
API
TVM Capital Life Science co-led a $16 million Series A financing for Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology. The funding will support the commercialization of vMap®, Vektor's AI-based arrhythmia analysis tool, aiming to revolutionize arrhythmia care and improve cardiac ablation outcomes.
Ask a question
How does the commercialization of vMap® reflect the evolving landscape of healthcare technology and innovation?
How might the integration of AI-based arrhythmia analysis tools in healthcare impact patient outcomes and treatment approaches?
What are the potential implications of TVM Capital Life Science's investment in the life sciences sector?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage